Lakcid Intima (Lactobacillus Gasseri Dsm 14869, Lactobacillus Rhamnosus Dsm 14870)

The two live bacterial strains colonise the vaginal epithelium and produce lactic acid and antimicrobial substances that lower the vaginal pH. This creates an environment that discourages pathogenic bacteria and yeast, while the strains compete for adhesion sites, helping to maintain a stable, healthy microbiota.

The dosage of Lakcid Intima is determined by the prescribing healthcare professional. The product is typically administered intravaginally according to the clinician’s instructions, which may vary based on the indication and individual patient factors.

Safety data for Lakcid Intima in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss use with their healthcare provider to weigh potential benefits against any unknown risks before starting the probiotic.

To order Lakcid Intima, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lakcid Intima contains two well‑studied strains, Lactobacillus gasseri DSM 14869 and Lactobacillus rhamnosus DSM 14870, which have demonstrated strong colonisation and acid‑producing capabilities. Compared with generic multi‑strain probiotics, these strains are specifically selected for vaginal health, offering targeted pH regulation and pathogen inhibition.

Lakcid Intima should be stored at room temperature, ideally below 25 °C. Keep the product in its original sealed packaging, protect it from moisture and direct sunlight, and avoid exposure to extreme temperatures to maintain bacterial viability.

Lakcid Intima is administered intravaginally. The patient inserts the supplied dosage form (e.g., capsule or tablet) into the vagina as directed by a healthcare professional, typically using a clean fingertip or applicator, and follows the prescribed schedule.

Serious risks, although rare, include allergic reactions such as rash, swelling, or breathing difficulty, and severe vaginal inflammation or ulceration. Immunocompromised individuals may be at higher risk for systemic infection. Any signs of serious adverse events should prompt immediate medical attention.

Individuals with a known hypersensitivity to Lactobacillus species or any component of the formulation should avoid using Lakcid Intima. Patients who are severely immunocompromised should consult their physician before use, as the live bacteria could pose a higher infection risk.